COCP vs NBIX · rev $105.0K vs P/E 45, rev $1.77B
Cocrystal Pharma Inc (COCP) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Cocrystal Pharma Inc (COCP) is a biotechnology company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported COCP revenue for 2026-06-30 was $105.0K. Net income was -$3.2M. Revenue was down 53.3% from 2026-03-31 to 2026-06-30. COCP currently screens at market cap $13.3M.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
COCP currently screens at market cap $13.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the COCP and NBIX stock pages for the full models.
Not investment advice.